NCT06602115

Brief Summary

Hematoma expansion is an independent predictor of poor prognosis and early neurological deterioration in patients with spontaneous intracerebral hemorrhage. Early identification of high-risk patients and timely targeted medical interventions may provide a crucial opportunity to limit hematoma growth and improve neurological outcomes. This study aims to develop an end-to-end deep learning model based on noncontrast computed tomography images to predict the risk of hematoma expansion in patients with spontaneous intracerebral hemorrhage. This model could serve as a valuable risk stratification tool for patients with hematoma expansion, facilitating targeted treatment and providing clinicians with streamlined decision-making support in emergency situations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

September 25, 2024

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 19, 2024

Status Verified

August 1, 2024

Enrollment Period

6 days

First QC Date

September 10, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

Spontaneous Intracerebral HemorrhageHematoma ExpansionDeep Learning

Outcome Measures

Primary Outcomes (1)

  • Prediction of Hematoma Expansion

    Proportion of patients with hematoma expansion

    From the onset of ICH symptoms to 72 hours after baseline CT

Study Arms (2)

Hematoma Expansion Group

Hematoma Expansion Group

Other: Observational study, no interventions involved

No Hematoma Expansion Group

Patients without hematoma expansion as defined in the study

Other: Observational study, no interventions involved

Interventions

Observational study, no interventions involved

Hematoma Expansion GroupNo Hematoma Expansion Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A multicenter retrospective cohort of 2000 patients with spontaneous intracerebral hemorrhage, including 500 cases of hematoma expansion and 1500 cases without hematoma expansion.

You may qualify if:

  • Primary, spontaneous (non-traumatic) intracerebral hemorrhage (ICH).
  • Age ≥ 18 years.
  • Baseline CT performed within 24 hours of ICH symptom onset or last seen well (LSW).
  • Follow-up CT within 72 hours.

You may not qualify if:

  • Secondary ICH caused by trauma, vascular anomalies (e.g., aneurysm, cavernous angioma, arteriovenous malformation), brain tumor, or hemorrhagic transformation in brain infarction.
  • Primary intraventricular hemorrhage (IVH).
  • Surgical treatment with external ventricular drain placement or craniotomy.
  • Obvious artifacts observed in CT images.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400016, China

Location

Related Publications (1)

  • Tran AT, Zeevi T, Haider SP, Abou Karam G, Berson ER, Tharmaseelan H, Qureshi AI, Sanelli PC, Werring DJ, Malhotra A, Petersen NH, de Havenon A, Falcone GJ, Sheth KN, Payabvash S. Uncertainty-aware deep-learning model for prediction of supratentorial hematoma expansion from admission non-contrast head computed tomography scan. NPJ Digit Med. 2024 Feb 6;7(1):26. doi: 10.1038/s41746-024-01007-w.

    PMID: 38321131BACKGROUND

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

September 25, 2024

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

September 19, 2024

Record last verified: 2024-08

Locations